Charles River Laboratories International (CRL) Change in Account Payables (2009 - 2026)

Charles River Laboratories International has reported Change in Account Payables for 18 years, with the latest figure at $821000.0 in Q2 2026.

• On a quarterly basis, Change in Account Payables rose 109.11% year-over-year to $821000.0 in Q2 2026; TTM through Jun 2026 was $7.9 million, a 5.97% decrease from a year earlier, with the FY2025 full-year figure at $2.9 million, up 120.1% from the prior year.
• Change in Account Payables was $821000.0 for Q2 2026 at Charles River Laboratories International, down from $20.5 million in the prior quarter.
• The five-year high for Change in Account Payables was $40.9 million in Q1 2022, with the low at -$41.3 million in Q2 2023.
• Average Change in Account Payables over 5 years is -$733611.1, with a median of -$1.1 million recorded in 2023.
• The largest YoY upside for Change in Account Payables was 3818.66% in 2025 against a maximum downside of 528.03% in 2025.
• Over 5 years, Change in Account Payables stood at -$8.6 million in 2022, then soared by 170.72% to $6.1 million in 2023, then plunged by 217.56% to -$7.2 million in 2024, then plunged by 427.84% to -$37.9 million in 2025, then soared by 102.17% to $821000.0 in 2026.
• The last three Change in Account Payables figures came in at $821000.0 (Q2 2026), $20.5 million (Q1 2026), and -$37.9 million (Q4 2025), per Business Quant data.